Accelerate Diagnostics

Dec 26, 2018

GenMark Fungal Blood Culture Test Clears FDA

The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.

Aug 23, 2018

Luminex Verigene MDx Panel Speeds Up AST, Reduces Cost, Study Finds

Premium

Clinicians identifying and treating S. aureus bloodstream infections reduced the median length of stay by 5.6 days and hospital cost by $13,341 per patient after using Luminex's assay.

Jun 15, 2017

FDA Clearance for GenMark's ePlex Intensifies Competition in Highly Plexed MDx Test Market

Premium

The firm will encounter stiff competition, particularly from BioMérieux and Luminex, but there are untapped opportunities for adoption, according to industry analysts.

Sep 16, 2016

Sepset Biosciences Developing Sepsis Test Based on Cellular Reprogramming Signature

Premium

The test is based on a biomarker signature that consists of a core set of 31 genes associated with endotoxin tolerance in sepsis patients.

Jul 22, 2016

Speed and Accuracy Top Considerations for Lab Directors in Choosing Sepsis Dx

Premium

Despite the array of tests available, some lab directors are still seeking broader functionalities and capabilities from the systems they purchase.

Jul 13, 2016

Accelerate Diagnostics' Pathogen ID, Antimicrobial Susceptibility Platform Moves Closer to Market

Premium

The company's test kit can ID pathogenic organisms and provide a measure of antibiotic susceptibility directly from positive blood culture samples.

Jul 11, 2016

Accelerate Diagnostics Submits Molecular, Phenotypic Detection Technologies for FDA Evaluation

The company's test kit provides identification and antimicrobial susceptibility testing of pathogens for patients suspected of bacteremia or fungemia.

Jan 29, 2016

District Court Dismisses Shareholders' Lawsuit Against Accelerate Diagnostics

The US District Court for the District of Arizona has granted Accelerate Dx's motion to dismiss a class-action lawsuit filed against it last year.

Aug 03, 2015

Accelerate Dx Posts Increase in Q2 Revenues, Net Loss

The firm's revenues nominally increased due to licensing agreements, while expenses also increased as the company ramps up its R&D efforts.

Jul 01, 2015

Accelerate Dx Lands CE Mark for ID/AST System, Initiates Clinical Trial Enrollment

The regulatory activity for the diagnostic platform follows ISO 13485:2003 certification in March. The firm is also planning a 510(k) submission to the FDA.

Pages

Breaking News

The Scan

Back for Another Round

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

Imprints Left Behind

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

Get the Most Out of It

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

Cell Papers Explore Translation, Messenger RNA Localization

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.